Psoriasis and risk of nonfatal cardiovascular disease in U.S. women: a cohort study

Background  Psoriasis has been linked to cardiovascular comorbidities in cross‐sectional studies, but evidence regarding the association between psoriasis and incident cardiovascular disease (CVD) is limited.

[1]  R. Dobson,et al.  British Association of Dermatologists , 2014 .

[2]  A. Barton,et al.  Polymorphisms in IL-1B distinguish between psoriasis of early and late onset. , 2014, The Journal of investigative dermatology.

[3]  Y. Momiyama,et al.  Inflammation, Atherosclerosis and Coronary Artery Disease , 2014, Clinical Medicine Insights. Cardiology.

[4]  L. Skov,et al.  Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study , 2011, Journal of internal medicine.

[5]  R. Stern,et al.  Very severe psoriasis is associated with increased noncardiovascular mortality but not with increased cardiovascular risk. , 2011, The Journal of investigative dermatology.

[6]  Andrea B Troxel,et al.  Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. , 2010, European heart journal.

[7]  A. Kimball,et al.  Coronary heart disease and stroke risk in patients with psoriasis: retrospective analysis. , 2010, The American journal of medicine.

[8]  R. Herings,et al.  Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort. , 2010, The Journal of investigative dermatology.

[9]  D. Ford,et al.  Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population‐based sample , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[10]  A. Troxel,et al.  The risk of stroke in patients with psoriasis. , 2009, The Journal of investigative dermatology.

[11]  A. Qureshi,et al.  Development and pilot‐testing of a psoriasis screening tool , 2009, The British journal of dermatology.

[12]  A. Qureshi,et al.  Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire , 2009, Archives of Dermatological Research.

[13]  S. Jick,et al.  Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case–control analysis , 2009, The British journal of dermatology.

[14]  A. Bowcock,et al.  New insights into the pathogenesis and genetics of psoriatic arthritis , 2009, Nature Clinical Practice Rheumatology.

[15]  D. Federman,et al.  Psoriasis: an opportunity to identify cardiovascular risk , 2009, The British journal of dermatology.

[16]  P. Ridker,et al.  AJC editor's consensus: psoriasis and coronary artery disease. , 2008, The American journal of cardiology.

[17]  P. Gisondi,et al.  Chronic Plaque Psoriasis Is Associated with Increased Arterial Stiffness , 2008, Dermatology.

[18]  D. Federman,et al.  Cytokine milieu in psoriasis and cardiovascular disease may explain the epidemiological findings relating these 2 diseases. , 2008, Archives of dermatology.

[19]  S. Jick,et al.  Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis , 2008, The British journal of dermatology.

[20]  B. Tom,et al.  Cardiovascular morbidity in psoriatic arthritis , 2008, Annals of the rheumatic diseases.

[21]  J. Gelfand,et al.  Psoriasis and metabolic disease: epidemiology and pathophysiology , 2008, Current opinion in rheumatology.

[22]  Elizabeth J Horn,et al.  Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey. , 2007, Journal of the American Academy of Dermatology.

[23]  D. Ciocon,et al.  Psoriasis and psoriatic arthritis: separate or one and the same? , 2007, The British journal of dermatology.

[24]  Hyon K. Choi,et al.  Smoking and the risk of psoriasis in women: Nurses' Health Study II. , 2007, The American journal of medicine.

[25]  A. Qureshi,et al.  The PASE questionnaire: pilot-testing a psoriatic arthritis screening and evaluation tool. , 2007, Journal of the American Academy of Dermatology.

[26]  Hyon K. Choi,et al.  Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. , 2007, Archives of internal medicine.

[27]  C. Griffiths,et al.  Pathogenesis and clinical features of psoriasis , 2007, The Lancet.

[28]  Anna Viner,et al.  The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. , 2007, Journal of the American Academy of Dermatology.

[29]  James G. Krueger,et al.  Pathogenesis and therapy of psoriasis , 2007, Nature.

[30]  D. Margolis,et al.  Risk of myocardial infarction in patients with psoriasis. , 2006, JAMA.

[31]  M. Weichenthal,et al.  Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis , 2006, Archives of Dermatological Research.

[32]  S. Heinzl.  [Relative and absolute]. , 2006, Medizinische Monatsschrift fur Pharmazeuten.

[33]  C. Turesson,et al.  Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. , 2005, The Journal of rheumatology.

[34]  ポール ポラキス.  Treatment of tumor , 2005 .

[35]  Anthony Howell,et al.  Preventing cancer, cardiovascular disease, and diabetes , 2005, The Lancet.

[36]  R. Kirsner,et al.  Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. , 2005, Journal of the American Academy of Dermatology.

[37]  M. Goodfield,et al.  Objective assessment of compliance with psoriasis treatment. , 2004, Archives of dermatology.

[38]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[39]  M. Lebwohl,et al.  Consensus conference: acitretin in combination with UVB or PUVA in the treatment of psoriasis. , 2001, Journal of the American Academy of Dermatology.

[40]  R. Brodell,et al.  A corticosteroid-induced flare of psoriasis. How to control or, better yet, avoid. , 1999, Postgraduate medicine.

[41]  A. Gottlieb,et al.  Cyclosporine consensus conference: with emphasis on the treatment of psoriasis. , 1998, Journal of the American Academy of Dermatology.

[42]  G W Sun,et al.  Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. , 1996, Journal of clinical epidemiology.

[43]  Per Capita,et al.  About the authors , 1995, Machine Vision and Applications.

[44]  R. Stern,et al.  The safety of etretinate as long-term therapy for psoriasis: results of the etretinate follow-up study. , 1995, Journal of the American Academy of Dermatology.

[45]  W. Willett,et al.  Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. , 1987, The New England journal of medicine.

[46]  E. Christophers,et al.  Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. , 1985, Journal of the American Academy of Dermatology.

[47]  F. D. Weinfeld,et al.  The National Survey of Stroke. Clinical findings. , 1981, Stroke.

[48]  P. Frost,et al.  Induction of glycosuria and hyperglycemia by topical corticosteroid therapy. , 1976, Archives of dermatology.

[49]  A. Sibley.  Research Report. Focus: smoking and the risk of psoriasis , 2008 .

[50]  B. Thiers.  Obesity, Waist Circumference, Weight Change, and the Risk of Psoriasis in Women: Nurses' Health Study II , 2008 .

[51]  E. Sijbrands,et al.  Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. , 2007, Atherosclerosis.

[52]  C. Bertini.  [Women nurses]. , 1989, Rivista dell'infermiere.

[53]  F. D. Weinfeld,et al.  National survey of stroke. , 1979, Transactions of the American Neurological Association.